Vanda Pharmaceuticals | VNDA - Market Capitalization


Vanda Pharmaceuticals reported $435M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Akebia Therapeutics USD 427M 297M Dec/2025
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
AstraZeneca USD 301.25B 13.1B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Esperion Therapeutics USD 885M 351M Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
J&J USD 579.15B 78.91B Mar/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Merck USD 297.1B 35.84B Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Pfizer USD 148.08B 6.51B May/2026
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
Takeda JPY 7.64T 774.9B Dec/2025
Teva Pharmaceutical Industries USD 34.27B 2.14B Mar/2026
Ultragenyx Pharmaceutical USD 2.04B 176M May/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024
Veracyte USD 2.62B 704M May/2026